New technique for cochlear implants to improve hearing
Stimulating the Cochlear Apex Without Longer Electrodes
This study is testing a new way to use cochlear implants to see if it can help people with hearing loss understand speech better and enjoy sound more.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 40 (estimated) |
| Ages | 18 Years to 90 Years |
| Sex | All |
| Sponsor | NYU Langone Health Academic / other |
| Locations | 1 site (New York, New York) |
| Trial ID | NCT06901674 on ClinicalTrials.gov |
What this trial studies
This study investigates a novel approach to cochlear implants that allows for stimulation across the entire cochlea without increasing the length of the electrode array. By utilizing a modified surgical technique and the Cochlear Nucleus CI632 implant, the study aims to enhance speech understanding and sound quality for individuals with moderate to profound sensorineural hearing loss. Participants will be evaluated based on their eligibility at the NYU cochlear implant center and may include those who have previously received a Cochlear Limited implant. The study will also explore how this new configuration affects the auditory system's encoding of temporal and spectral information.
Who should consider this trial
Good fit: Ideal candidates are individuals diagnosed with moderate to profound sensorineural hearing loss who are eligible for a Cochlear Limited cochlear implant.
Not a fit: Patients who are under 18 years old or have not chosen a Cochlear Limited implant may not benefit from this study.
Why it matters
Potential benefit: If successful, this technique could significantly improve speech understanding and sound quality for cochlear implant users.
How similar studies have performed: While similar approaches have been explored, this specific technique is novel and has not been extensively tested in prior studies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Participants in this study must have already been evaluated at the NYU cochlear implant center as being eligible for a cochlear implant. * They must have decided to receive a cochlear implant manufactured by Cochlear Limited and have been diagnosed with a moderate to profound sensorineural hearing loss in the ear to be implanted. * Individuals who have already been implanted with a cochlear implant manufactured by Cochlear Limited with or without this new approach may also participate in this study. Exclusion Criteria: * They are under the age of 18 * They have not been diagnosed with a moderate to profound sensorineural hearing loss in the ear to be implanted * Have \>15 years of profound deafness * Have not chosen to receive a cochlear implant manufactured by Cochlear Limited * Are pregnant or plan to conceive within 6 months of consenting
Where this trial is running
New York, New York
- NYU Langone Health — New York, New York, United States (Recruiting)
Study contacts
- Principal investigator: David M. Landsberger, Ph.D. — NYU Langone Health
- Study coordinator: David M. Landsberger, Ph.D.
- Email: David.landsberger@nyulangone.org
- Phone: 212-263-8455
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.